DLG2 variants in patients with pubertal disorders

Genet Med. 2020 Aug;22(8):1329-1337. doi: 10.1038/s41436-020-0803-8. Epub 2020 Apr 28.

Abstract

Purpose: Impaired function of gonadotropin-releasing hormone (GnRH) neurons can cause a phenotypic spectrum ranging from delayed puberty to isolated hypogonadotropic hypogonadism (IHH). We sought to identify a new genetic etiology for these conditions.

Methods: Exome sequencing was performed in an extended family with autosomal dominant, markedly delayed puberty. The effects of the variant were studied in a GnRH neuronal cell line. Variants in the same gene were sought in a large cohort of individuals with IHH.

Results: We identified a rare missense variant (F900V) in DLG2 (which encodes PSD-93) that cosegregated with the delayed puberty. The variant decreased GnRH expression in vitro. PSD-93 is an anchoring protein of NMDA receptors, a type of glutamate receptor that has been implicated in the control of puberty in laboratory animals. The F900V variant impaired the interaction between PSD-93 and a known binding partner, Fyn, which phosphorylates NMDA receptors. Variants in DLG2 that also decreased GnRH expression were identified in three unrelated families with IHH.

Conclusion: The findings indicate that variants in DLG2/PSD-93 cause autosomal dominant delayed puberty and may also contribute to IHH. The findings also suggest that the pathogenesis involves impaired NMDA receptor signaling and consequently decreased GnRH secretion.

Keywords: DLG2; NMDA receptors; PSD-93; hypogonadotropic hypogonadism; puberty.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Exome Sequencing
  • Gonadotropin-Releasing Hormone* / genetics
  • Guanylate Kinases
  • Humans
  • Hypogonadism* / genetics
  • Proteins
  • Signal Transduction
  • Tumor Suppressor Proteins

Substances

  • Proteins
  • Tumor Suppressor Proteins
  • Gonadotropin-Releasing Hormone
  • DLG2 protein, human
  • Guanylate Kinases